Amgen CEO to step down
Kevin Sharer, chairman and CEO of Amgen, is set to retire in May, the Thousand Oaks-based company said on Dec. 15. Current president and chief operating officer Robert Bradway will become the company’s new CEO. Sharer led Amgen, the largest private-sector employer in Ventura County, for 11 years. He oversaw the company’s transition from the Read More →
Amgen wraps up buyback auction
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”08-06-2011″ enddate=”08-12-2011″ width=”300″ height=”245″] Amgen, based in Thousand Oaks, expects to repurchase 9.6 percent of its outstanding shares at a price of $60 per share after asking shareholders to name their price in a buyback auction. The biotech giant and major Ventura County employer said Dec. 8 it had completed Read More →
Semtech’s earnings rise
[wikichart align=”right” ticker=”NASDAQ:SMTC” showannotations=”true” livequote=”true” startdate=”30-05-2011″ enddate=”30-11-2011″ width=”300″ height=”245″] Camarillo-based Semtech, a chip design firm, posted 67 percent increase in quarterly earnings on a slight increase in sales for the most recent quarter. Semtech, which is in its 2012 fiscal year, said third quarter net income came to $27 million, compared with $16.1 million a Read More →
Amgen kicks off debt offering
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”30-05-2011″ enddate=”30-11-2011″ width=”300″ height=”245″] Amgen has priced more than $1 billion in debt offerings as it loads up on cash for its massive stock buyback and dividend program. The company said it had priced $550 million of senior notes due 2018 and an additional $475 million in senior notes due Read More →